- Home
- PROK vs MLP Comparison
PROK vs MLP Comparison
Compare PROK & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- MLP
- Stock Information
- Founded
- PROK 2015
- MLP 1909
- Country
- PROK United States
- MLP United States
- Employees
- PROK N/A
- MLP N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- MLP Real Estate
- Sector
- PROK Health Care
- MLP Finance
- Exchange
- PROK Nasdaq
- MLP Nasdaq
- Market Cap
- PROK 384.2M
- MLP 344.7M
- IPO Year
- PROK N/A
- MLP 1972
- Fundamental
- Price
- PROK $2.35
- MLP $17.48
- Analyst Decision
- PROK Buy
- MLP
- Analyst Count
- PROK 5
- MLP 0
- Target Price
- PROK $6.25
- MLP N/A
- AVG Volume (30 Days)
- PROK 3.3M
- MLP 13.7K
- Earning Date
- PROK 08-12-2025
- MLP 08-22-2025
- Dividend Yield
- PROK N/A
- MLP N/A
- EPS Growth
- PROK N/A
- MLP N/A
- EPS
- PROK N/A
- MLP N/A
- Revenue
- PROK $527,000.00
- MLP $14,886,000.00
- Revenue This Year
- PROK $105.79
- MLP N/A
- Revenue Next Year
- PROK N/A
- MLP N/A
- P/E Ratio
- PROK N/A
- MLP N/A
- Revenue Growth
- PROK N/A
- MLP 57.13
- 52 Week Low
- PROK $0.46
- MLP $14.05
- 52 Week High
- PROK $7.13
- MLP $26.46
- Technical
- Relative Strength Index (RSI)
- PROK 43.77
- MLP 55.11
- Support Level
- PROK $2.16
- MLP $16.06
- Resistance Level
- PROK $2.46
- MLP $17.49
- Average True Range (ATR)
- PROK 0.34
- MLP 0.58
- MACD
- PROK -0.16
- MLP 0.07
- Stochastic Oscillator
- PROK 7.14
- MLP 99.39
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.